Medicus Pharma Ltd. has announced the appointment of Andrew Smith as Chief Operating Officer. Andrew brings over three decades of experience in asset management and financial operations, having previously served as Chief Executive of SR Asset Management and Co-Head of Americas at Aberdeen Asset Management Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.